TY - JOUR
T1 - Safety/Efficacy of DOAC Versus Aspirin for Reduction of Risk of Cerebrovascular Events Following VT Ablation
AU - Lakkireddy, Dhanunjaya
AU - Shenthar, Jayaprakash
AU - Garg, Jalaj
AU - Padmanabhan, Deepak
AU - Gopinathannair, Rakesh
AU - Di Biase, Luigi
AU - Romero, Jorge
AU - Mohanty, Sanghamitra
AU - Burkhardt, David J.
AU - Al-Ahmad, Amin
AU - Atkins, Donita
AU - Bommana, Sudha
AU - Natale, Andrea
N1 - Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
PY - 2021/12
Y1 - 2021/12
KW - PVC ablation
KW - STROKE-VT
KW - VT ablation
KW - anticoagulation
KW - Anticoagulants
KW - Catheter Ablation/adverse effects
KW - Humans
KW - Tachycardia, Ventricular/epidemiology
KW - Endocardium/surgery
KW - Aspirin/adverse effects
UR - https://www.scopus.com/pages/publications/85114841178
UR - https://www.scopus.com/pages/publications/85114841178#tab=citedBy
UR - https://www.mendeley.com/catalogue/966e273a-2ae7-3409-95f4-aa26d3691c0f/
U2 - 10.1016/j.jacep.2021.07.010
DO - 10.1016/j.jacep.2021.07.010
M3 - Article
C2 - 34393085
AN - SCOPUS:85114841178
SN - 2405-500X
VL - 7
SP - 1493
EP - 1501
JO - JACC: Clinical Electrophysiology
JF - JACC: Clinical Electrophysiology
IS - 12
ER -